Your browser is unsupported

We recommend using the latest version of IE11, Edge, Chrome, Firefox or Safari.

Management of severe asthma – role of monoclonal antibodies

Kaitlin E. Miles, PharmD, BCPS

Kaitlin E. Miles, PharmD, BCPS
Clinical Assistant Professor/Academic Detailing Pharmacist
Medication Review and Academic Detailing (MRAD)/Illinois ADVANCE
University of Illinois at Chicago College of Pharmacy

Learning Objectives:
At the completion of this activity, the participant will be able to:

  • Explain the pathophysiology of Type 2 inflammation in severe asthma
  • Compare the profiles and product information of the monoclonal antibodies for severe asthma
  • Review the approach to management of severe asthma as recommended by the Global Initiative for Asthma (GINA)
Number of Credits Hours 1.0 contact hour Fee: $35.00
Release Date: April 21, 2022 Expiration Date: April 14, 2024

Go to activity